切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 266 -269. doi: 10.3877/cma.j.issn.2095-3232.2017.04.007

所属专题： 文献；

临床研究

贲门周围血管离断术后并发症发生的影响因素分析
刘阳1,†(), 赵耀1, 黎一鸣1, 陈熹1, 刘清峰1   
  1. 1. 71004　西安交通大学医学院第二附属医院普通外科
  • 收稿日期:2017-04-25 出版日期:2017-08-10
  • 通信作者: 刘阳

Influencing factors analysis for the incidence of postoperative complications after pericardical devascularization

Yang Liu1,†(), Yao Zhao1, Yiming Li1, Xi Chen1, Qingfeng Liu1   

  1. 1. Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, China
  • Received:2017-04-25 Published:2017-08-10
  • Corresponding author: Yang Liu
  • About author:
    Corresponding author:Liu Yang, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

刘阳, 赵耀, 黎一鸣, 陈熹, 刘清峰. 贲门周围血管离断术后并发症发生的影响因素分析[J]. 中华肝脏外科手术学电子杂志, 2017, 06(04): 266-269.

Yang Liu, Yao Zhao, Yiming Li, Xi Chen, Qingfeng Liu. Influencing factors analysis for the incidence of postoperative complications after pericardical devascularization[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(04): 266-269.

目的

探讨贲门周围血管离断术后并发症发生的影响因素及其对患者远期生存的影响。

方法

回顾性分析2009年9月至2012年9月在西安交通大学医学院第二附属医院行贲门周围血管离断术的268例门静脉高压症患者临床资料。患者均签署知情同意书，符合医学伦理学规定。其中男160例，女108例；年龄22～77岁，中位年龄47岁；均行脾切除+贲门周围血管离断术。根据患者术后是否发生并发症分为并发症组（57例）和无并发症组（211例）。比较两组围手术期资料，并对患者的生存进行随访。两组临床资料比较采用t检验或Wilcoxon秩和检验，率的比较采用χ2检验。

结果

并发症组既往总出血量>1 000 ml及有内镜下治疗史患者百分率分别为51%（29/57）、26%（15/57），明显高于无并发症组的29%（61/211）、12%（26/211） （χ2=8.749，6.781；P<0.05）。并发症组ALT、AST、PT分别为35（22）U/L、50（31）U/L、（14.1±1.7）s，明显高于无并发症组的26（21）U/L、37（22）U/L、（13.5±1.6）s （Z=2.691，Z=3.063，t=2.479；P<0.05）。随访期间并发症组死亡6例，无并发症组11例，两组患者生存率比较差异无统计学意义（χ2=1.008，P>0.05）。并发症组发生肝细胞癌3例，无并发症组5例，截止投稿日期患者均带瘤生存。

结论

术前大出血、内镜下治疗史、肝功能和凝血功能较差是贲门周围血管离断术后并发症发生的影响因素，但术后并发症的发生并不影响患者远期生存。

关键词: 断流术, 脾切除术, 高血压，门静脉, 手术后并发症, 危险因素
Objective

To investigate the influencing factors for the incidence of postoperative complications after pericardical devascularization and evaluate its effect upon the long-term survival of the patients.

Methods

Clinical data of 268 patients with portal hypertension who underwent pericardical devascularization in the Second Affiliated Hospital of Xi'an Jiaotong University School of Medicine between September 2009 and September 2012 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among the patients, 160 cases were males and 108 were females, aged 22-77 years old with a median age of 47 years old. The patients all underwent splenectomy + pericardical devascularization. According to the postoperative complications happened or not, the patients were divided into the complication group (n=57) and non-complication group (n=211). The perioperative data of two groups were compared and the postoperative survival was followed up. The clinical data of two groups were compared using t test or Wilcoxon rank sum test. The rate was compared using Chi-square test.

Results

The percentage of patients with medical history of total blood loss >1 000 ml and endoscopic treatment in the complication group was respectively 51%(29/57) and 26%(15/57), significantly higher than 29%(61/211) and 12%(26/211) in the non-complication group (χ2=8.749, 6.781; P<0.05). The level of ALT, AST and PT in the complication group was respectively 35(22) U/L, 50(31) U/L and (14.1±1.7) s, significantly higher than 26(21) U/L, 37(22) U/L and (13.5±1.6) s in the non-complication group (Z=2.691, Z=3.063, t=2.479; P<0.05). During postoperative follow-up, 6 patients died in the complication group and 11 in the non-complication group. There was no significant significance in the survival rate between two groups (χ2=1.008, P>0.05). Three cases of hepatocellular carcinoma occurred in the complication group and 5 in the non-complication group, and they all survived until the submission date.

Conclusions

Preoperative massive hemorrhage, medical history of endoscopic treatment, poor liver function and coagulation function are the influencing factors for the incidence of postoperative complications after pericardical devascularization. But these postoperative complications exert no effect upon the long-term survival of the patients.

Key words: Devascularization, Splenectomy, Hypertension, portal, Postoperative complications, Risk factors
表1 并发症组与无并发症组患者围手术期资料比较
临床参数 并发症组 无并发症组 统计值 P值
年龄（岁，±s） 49±11 48±10 0t=0.656 0.513
性别（例） ? ? χ2=2.771 0.096
? 男 40 120 ? ?
? 女 17 091 ? ?
上消化道出血史≥2次（例） 22 052 χ2=3.700 0.054
既往总出血量>1 000 ml（例） 29 061 χ2=8.749 0.003
内镜下治疗史（例） 15 026 χ2=6.781 0.009
肝病病因 ? ? χ2=0.373 0.830
? 乙肝+丙肝 45 174 ? ?
? 乙肝 10 031 ? ?
? 丙肝 02 06 ? ?
肝硬化确诊时间[月，M(QR)] 12（19） 18（18） 00Z=-0.136 0.892
门静脉直径[cm，M(QR)] 1.40（0.10） 1.50（0.10） 00Z=-0.300 0.764
脾静脉直径（cm，±s） 1.20±0.30 1.21±0.30 00t=-0.223 0.823
脾脏最大长径（cm，±s） 21.8±5.70 21.9±7.60 00t=-0.093 0.926
WBC[×1012/L，M(QR)] 1.8（2.4） 2.2（1.3） 00Z=-1.548 0.224
Hb（g/L，±s） 099±200 103±190 00t=-1.343 0.180
Plt[×109/L，M(QR)] 38（28） 40（26） 00Z=-1.383 0.122
ALT[U/L，M(QR)] 35（22） 26（21） 0Z=2.691 0.007
AST[U/L，M(QR)] 50（31） 37（22） 0Z=3.063 0.002
ALB（g/L，±s） 37±30 38±40 00t=-0.649 0.517
TB[μmol/L，M(QR)] 33（17） 24（13） 00Z=1.8540 0.640
PT（s，±s） 14.1±1.70 13.5±1.60 00t=2.4790 0.014
术中出血量[ml，M(QR)] 0800（1 100） 600（550） 00Z=1.1910 0.234
[1]
Yao HS, Wang WJ, Wang Q, et al. Randomized clinical trial of vessel sealing system (LigaSure) in esophagogastric devascularization and splenectomy in patients with portal hypertension[J]. Am J Surg, 2011, 202(1):82-90.
[2]
Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis[J]. J Hepatol, 2011, 54(1):78-88.
[3]
Zheng X, Liu Q, Yao Y. Laparoscopic splenectomy and esophagogastric devascularization is a safe, effective, minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding[J]. Surg Innov, 2013, 20(1):32-39.
[4]
Chen XD, He FQ, Yang L, et al. Laparoscopic splenectomy with or without devascularization of the stomach for liver cirrhosis and portal hypertension: a systematic review[J]. ANZ J Surg, 2013, 83(3):122-128.
[5]
Cheng Z, Li JW, Chen J, et al. Therapeutic effects of laparoscopic splenectomy and esophagogastric devascularization on liver cirrhosis and portal hypertension in 204 cases[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(9):612-616.
[6]
Zhe C, Jian-wei L, Jian C, et al. Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: a comparative study[J]. J Gastrointest Surg, 2013, 17(4):654-659.
[7]
Zuiki T, Hosoya Y, Sakuma Y, et al. Laparoscopic gastric devascularization without splenectomy is effective for the treatment of gastric varices[J]. Int J Surg Case Rep, 2016(19):119-123.
[8]
Jiang GQ, Bai DS, Chen P, et al. Laparoscopic splenectomy and azygoportal disconnection: a systematic review[J]. JSLS, 2015, 19(4):e2015.00091.
[9]
Zong GQ, Fei Y, Chen J, et al. Selective double disconnection for cirrhotic portal hypertension[J]. J Surg Res, 2014, 192(2):383-389.
[10]
Liu Y, Li Y, Ma J, et al. A modified Hassab's operation for portal hypertension: experience with 562 cases[J]. J Surg Res, 2013, 185(1): 463-468.
[11]
Wang Q, Ding X. A comparative study of the efficacy of the modified Sugiura procedure and the Hassab procedure for treatment of rebleeding after endoscopic variceal ligation due to portal hypertension[J]. Am Surg, 2016, 82(6):557-564.
[12]
陈平，姜海涛．快速康复外科理念对门脉高压症患者门奇断流术后并发症发生的影响[J]．肝胆外科杂志，2013，21(6):444-447.
[13]
洪文，丛鹏．肝硬化门静脉高压门体断流脾切除术后并发症的发生及影响因素分析[J]．国际外科学杂志，2014，41(10):669-673.
[14]
潘洁，唐哲，李捷，等．吲哚菁绿试验术前评估脾切断流术[J]．中华实验外科杂志，2013，30(4):839-841.
[15]
Tonomura Y, Kato Y, Hanafusa H, et al. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats[J]. J Appl Toxicol, 2015, 35(2):165-172.
[16]
Elwakil R, Al Breedy AM, Gabal HH. Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study[J]. Hepatol Int, 2016, 10(6):965-973.
[17]
Sarin SK, Kumar A, Angus PW, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations[J]. Hepatol Int, 2011, 5(2):607-624.
[18]
Kozhura VL, Novoderzhkina IS, Kirsanova AK. Acute and massive hemorrhage: mechanisms of compensation and damage[J]. Anesteziol Reanimatol, 2002(6):9-13.
[19]
胡森，李琳，侯经元，等．失血性休克延迟复苏对犬血流动力学和内脏灌流的影响[J]．中华急诊医学杂志，2011，20(7):722-725.
[20]
Zhang L, Luo N, Liu J, et al. Emulsified isoflurane preconditioning protects against liver and lung injury in rat model of hemorrhagic shock[J]. J Surg Res, 2011, 171(2):783-790.
[1] 刘欢颜, 华扬, 贾凌云, 赵新宇, 刘蓓蓓. 颈内动脉闭塞病变管腔结构和血流动力学特征分析[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 809-815.
[2] 马艳波, 华扬, 刘桂梅, 孟秀峰, 崔立平. 中青年人颈动脉粥样硬化病变的相关危险因素分析[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 822-826.
[3] 陈旭渊, 罗仕云, 李文忠, 李毅. 腺源性肛瘘经手术治疗后创面愈合困难的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 82-85.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[6] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[7] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[8] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[9] 毛永欢, 仝瀚文, 缪骥, 王行舟, 沈晓菲, 喻春钊. 造口旁疝危险因素预测模型构建[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 682-687.
[10] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[11] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[12] 陆猛桂, 黄斌, 李秋林, 何媛梅. 蜂蛰伤患者发生多器官功能障碍综合征的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1010-1015.
[13] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 孟科, 李燕, 闫婧爽, 闫斌. 胶囊内镜胃通过时间的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 671-675.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号